首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Identification of Novel Microsatellite Markers &1 Mb from the HTT CAG Repeat and Development of a Single-Tube Tridecaplex PCR Panel of Highly Polymorphic Markers for Preimplantation Genetic Diagnosis of Huntington Disease
【24h】

Identification of Novel Microsatellite Markers &1 Mb from the HTT CAG Repeat and Development of a Single-Tube Tridecaplex PCR Panel of Highly Polymorphic Markers for Preimplantation Genetic Diagnosis of Huntington Disease

机译:从HTT CAG重复中鉴定<1 Mb的新型微卫星标记,并开发用于亨廷顿病植入前遗传学诊断的高度多态标记的单管Tridecaplex PCR板

获取原文
           

摘要

BACKGROUND: Preimplantation genetic diagnosis (PGD) of Huntington disease (HD) generally employs linkage analysis of flanking microsatellite markers to complement direct mutation testing, as well as for exclusion testing. Thus far, only 10 linked markers have been developed for use in HD PGD, with a maximum of 3 markers coamplified successfully. We aimed to develop a single-tube multiplex PCR panel of highly polymorphic markers to simplify HD PGD.METHODS: An in silico search was performed to identify all markers within 1 Mb flanking the huntingtin ( HTT ) gene. Selected markers were optimized in a single-tube PCR panel, and their polymorphism indices were determined in 2 populations. The panel was tested on 63 single cells to validate its utility in PGD.RESULTS: We identified 102 markers in silico, of which 56 satisfied the selection criteria. After initial testing, 12 markers with potentially high heterozygosity were optimized into a single-tube PCR panel together with a 13th more distally located marker. Analysis of DNA from 183 Chinese and Caucasian individuals revealed high polymorphism indices for all markers (polymorphism information content 0.5), with observed heterozygosities ranging from 0.5–0.92. All individuals were heterozygous for at least 5 markers, with 99.5% of individuals heterozygous for at least 2 markers upstream and downstream of the HTT CAG repeat.CONCLUSIONS: The tridecaplex marker assay amplified reliably from single cells either directly or after whole genome amplification, thus validating its standalone use in HD exclusion PGD or as a complement to HTT CAG repeat expansion-mutation detection.
机译:背景:亨廷顿病(HD)的植入前遗传学诊断(PGD)通常采用侧翼微卫星标记的连锁分析来补充直接突变测试以及排除测试。迄今为止,仅开发了10种链接标记用于HD PGD,最多成功扩增了3个标记。我们旨在开发一种具有高度多态性标记物的单管多重PCR面板,以简化HD PGD。方法:进行了计算机搜索,鉴定了亨廷顿(HTT)基因两侧1 Mb内的所有标记物。在单管PCR面板中优化选定的标记,并在2个群体中确定其多态性指数。该小组在63个单细胞上进行了测试,以验证其在PGD中的效用。结果:我们在计算机上鉴定了102个标记,其中56个满足选择标准。初步测试后,将具有潜在高杂合性的12种标记物与第13个位于远端的标记物一起优化到单管PCR面板中。对来自183名中国人和高加索人的DNA的分析显示,所有标记的多态性指数都很高(多态性信息含量> 0.5),并且观察到的杂合度范围为0.5-0.92。所有个体均在至少5个标记上是杂合的,其中99.5%的个体在HTT CAG重复序列的上游和下游至少2个标记上是杂合的。结论:十三链标记测定可直接或在全基因组扩增后从单细胞可靠地扩增。验证其在HD排除PGD中的独立使用,或作为HTT CAG重复扩展突变检测的补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号